n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Cardiovascular Stroke in 10 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, YC | 1 |
| Shi, CL | 1 |
| Zhou, M | 1 |
| Liu, Y | 1 |
| Zhang, G | 1 |
| Hou, SA | 1 |
| Weber, NC | 2 |
| Frässdorf, J | 1 |
| Ratajczak, C | 1 |
| Grueber, Y | 1 |
| Schlack, W | 2 |
| Hollmann, MW | 2 |
| Preckel, B | 2 |
| Huhn, R | 1 |
| Heinen, A | 1 |
| Hieber, S | 1 |
| Tosaka, S | 1 |
| Tosaka, R | 1 |
| Matsumoto, S | 1 |
| Maekawa, T | 1 |
| Cho, S | 1 |
| Sumikawa, K | 1 |
| Kodani, E | 1 |
| Xuan, YT | 2 |
| Shinmura, K | 3 |
| Takano, H | 2 |
| Tang, XL | 3 |
| Bolli, R | 3 |
| LaPointe, MC | 1 |
| Mendez, M | 1 |
| Leung, A | 1 |
| Tao, Z | 1 |
| Yang, XP | 1 |
| Jiang, X | 2 |
| Shi, E | 2 |
| Nakajima, Y | 2 |
| Sato, S | 2 |
| Ohno, K | 1 |
| Yue, H | 1 |
| Wang, Y | 1 |
| Liu, SQ | 1 |
| Bhatnagar, A | 1 |
| Guo, Y | 1 |
| Bao, W | 1 |
| Wu, WJ | 1 |
10 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Cardiovascular Stroke
| Article | Year |
|---|---|
Selective cyclooxygenase-2 inhibitor NS-398 attenuates myocardial fibrosis in mice after myocardial infarction via Snail signaling pathway.
Topics: Animals; Cyclooxygenase 2 Inhibitors; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardial Infarctio | 2017 |
Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
Topics: Animals; Cyclooxygenase 2; Heart Rate; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarc | 2008 |
Helium-induced late preconditioning in the rat heart in vivo.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Adminis | 2009 |
Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.
Topics: Animals; Cardiotonic Agents; Coronary Vessels; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Heart; | 2011 |
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness; | 2002 |
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
Topics: Animals; Cardiomegaly; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhib | 2004 |
Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cardiotonic Agents; Cyclooxygenase 1; Cyclooxygenase 2; Cyclo | 2005 |
COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cardiotonic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2006 |
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2000 |
Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Heart; Ischemic P | 2000 |